Literature DB >> 29619520

Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.

Sung-Hye You1,2, Tae Jin Yun3,4, Hye Jeong Choi1,2, Roh-Eul Yoo1,2, Koung Mi Kang1,2, Seung Hong Choi1,2, Ji-Hoon Kim1,2, Chul-Ho Sohn1,2.   

Abstract

OBJECTIVES: To evaluate the diagnostic performance of arterial spin labelling perfusion weighted images (ASL-PWIs) to differentiate primary CNS lymphoma (PCNSL) from glioblastoma (GBM).
METHODS: ASL-PWIs of pathologically confirmed PCNSL (n = 21) or GBM (n = 93) were analysed. For qualitative analysis, tumours were visually scored into five categories based on ASL-CBF maps. For quantitative analysis, normalised CBF values were derived by contralateral grey matter (GM) in intra- and peritumoral areas (nCBFintratumoral and nCBFperitumoral, respectively). Visual scoring scales and quantitative parameters from PCNSL and GBM were compared. In addition, the area under the receiver-operating characteristic (ROC) curve was used to determine the diagnostic accuracy of ASL-PWI for differentiating PCNSL from GBM. Weighted kappa or intraclass correlation coefficients (ICCs) were used to assess reliability between two observers.
RESULTS: In qualitative analysis, scores 5 (CBFintratumoral>CBFGM, 68.8% [64/93]) and 4 (CBFintratumoralCBFGM, 47.6% [10/21]) were the most frequently reported scores for GBM and PCNSL, respectively. In quantitative analysis, both nCBFintratumoral and nCBFperitumoral in PCNSL were significantly lower than those in the GBM (nCBFintratumoral, 0.89 ± 0.59 [mean and SD] vs. 2.68 ± 1.89, p < 0.001; nCBFperitumoral, 0.17 ± 0.08 vs. 0.45 ± 0.28, p < 0.001). nCBFperitumoral demonstrated the best diagnostic performance (area under the ROC curve: visual scoring, 0.814; nCBFintratumoral, 0.849; nCBFperitumoral, 0.908; p < 0.001 for all). Interobserver agreements for visual scoring (weighted kappa = 0.869), nCBFintratumoral_GM (ICC = 0.958) and nCBFperitumoral_GM (ICC = 0.947) were all excellent.
CONCLUSIONS: ASL-PWI performs well in differentiating PCNSL from GBM in both qualitative and quantitative analyses. KEY POINTS: • ASL-PWI performs well (AUC > 0.8) in differentiating PCNSL from GBM. • The visual scoring template demonstrated good diagnostic performance, similar to quantitative analysis. • nCBFperitumoral demonstrated better diagnostic performance than nCBFintratumoral or visual scoring.

Entities:  

Keywords:  Brain neoplasms; Glioblastoma; Lymphoma; Magnetic resonance imaging; Perfusion imaging

Mesh:

Substances:

Year:  2018        PMID: 29619520     DOI: 10.1007/s00330-018-5359-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

Review 1.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Authors:  Soonmee Cha; Edmond A Knopp; Glyn Johnson; Stephan G Wetzel; Andrew W Litt; David Zagzag
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

2.  Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.

Authors:  Carissa M White; Whitney B Pope; Taryar Zaw; Joe Qiao; Kourosh M Naeini; Albert Lai; Phioanh L Nghiemphu; J J Wang; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  J Neuroimaging       Date:  2012-06-05       Impact factor: 2.486

3.  Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities.

Authors:  A J Bastos-Leite; J P A Kuijer; S A R B Rombouts; E Sanz-Arigita; E C van Straaten; A A Gouw; W M van der Flier; P Scheltens; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-01       Impact factor: 3.825

4.  Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Authors:  Bahattin Hakyemez; Cuneyt Erdogan; Naile Bolca; Nalan Yildirim; Gokhan Gokalp; Mufit Parlak
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

5.  Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.

Authors:  S Nakajima; T Okada; A Yamamoto; M Kanagaki; Y Fushimi; T Okada; Y Arakawa; Y Takagi; S Miyamoto; K Togashi
Journal:  Clin Radiol       Date:  2015-09-14       Impact factor: 2.350

6.  Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yoshimoto; Satoshi O Suzuki; Koichiro Abe; Kazufumi Kikuchi; Yasuhiro Maruoka; Masahiro Mizoguchi; Toru Iwaki; Hiroshi Honda
Journal:  Neuroradiology       Date:  2012-09-09       Impact factor: 2.804

7.  Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.

Authors:  Koji Yamashita; Akio Hiwatashi; Osamu Togao; Kazufumi Kikuchi; Yoshiyuki Kitamura; Masahiro Mizoguchi; Koji Yoshimoto; Daisuke Kuga; Satoshi O Suzuki; Shingo Baba; Takuro Isoda; Toru Iwaki; Koji Iihara; Hiroshi Honda
Journal:  J Magn Reson Imaging       Date:  2016-04-19       Impact factor: 4.813

Review 8.  Primary central nervous system lymphoma.

Authors:  Andrés J M Ferreri; Michele Reni
Journal:  Crit Rev Oncol Hematol       Date:  2007-06-21       Impact factor: 6.312

9.  Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas.

Authors:  Roh-Eul Yoo; Seung Hong Choi; Hye Rim Cho; Tae Min Kim; Se-Hoon Lee; Chul-Kee Park; Sung-Hye Park; Il Han Kim; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn; Moon Hee Han; Kee Hyun Chang
Journal:  J Magn Reson Imaging       Date:  2013-02-06       Impact factor: 4.813

10.  Cellular characterization of the peritumoral edema zone in malignant brain tumors.

Authors:  Tobias Engelhorn; Nic E Savaskan; Marc A Schwarz; Jürgen Kreutzer; Eric P Meyer; Eric Hahnen; Oliver Ganslandt; Arnd Dörfler; Christopher Nimsky; Michael Buchfelder; Ilker Y Eyüpoglu
Journal:  Cancer Sci       Date:  2009-07-24       Impact factor: 6.716

View more
  13 in total

1.  Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.

Authors:  Shayan Sirat Maheen Anwar; Mirza Zain Baig; Altaf Ali Laghari; Fatima Mubarak; Muhammad Shahzad Shamim; Umaima Ayesha Jilani; Muhammad Usman Khalid
Journal:  Neuroradiol J       Date:  2019-06-12

2.  Pseudo-continuous arterial spin labelling shows high diagnostic performance in the detection of postoperative residual lesion in hyper-vascularised adult brain tumours.

Authors:  Clara Cohen; Bruno Law-Ye; Didier Dormont; Delphine Leclercq; Laurent Capelle; Marc Sanson; Damien Galanaud; Nadya Pyatigorskaya
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

3.  Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.

Authors:  Yaoming Qu; Dexia Kong; Haitao Wen; Xiaochan Ou; Qihong Rui; Xianlong Wang; Doris D Lin; Qin Qin; Zhibo Wen
Journal:  Eur Radiol       Date:  2022-01-23       Impact factor: 5.315

4.  3D pseudo-continuous arterial spin labeling-MRI (3D PCASL-MRI) in the differential diagnosis between glioblastomas and primary central nervous system lymphomas.

Authors:  A I Batalov; R M Afandiev; N E Zakharova; E L Pogosbekyan; A A Shulgina; G L Kobyakov; A A Potapov; I N Pronin
Journal:  Neuroradiology       Date:  2022-02-03       Impact factor: 2.995

Review 5.  Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging-a comprehensive overview.

Authors:  Anna Falk Delgado; Danielle Van Westen; Markus Nilsson; Linda Knutsson; Pia C Sundgren; Elna-Marie Larsson; Alberto Falk Delgado
Journal:  Insights Imaging       Date:  2019-08-23

6.  A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.

Authors:  Jingjing Li; Ming Xue; Shuo Yan; Chunshuang Guan; Ruming Xie; Budong Chen
Journal:  BMC Infect Dis       Date:  2021-02-10       Impact factor: 3.090

7.  Deep Learning With Data Enhancement for the Differentiation of Solitary and Multiple Cerebral Glioblastoma, Lymphoma, and Tumefactive Demyelinating Lesion.

Authors:  Yu Zhang; Kewei Liang; Jiaqi He; He Ma; Hongyan Chen; Fei Zheng; Lingling Zhang; Xinsheng Wang; Xibo Ma; Xuzhu Chen
Journal:  Front Oncol       Date:  2021-08-18       Impact factor: 6.244

8.  Differentiation of primary central nervous system lymphoma from glioblastoma using optical coherence tomography based on attention ResNet.

Authors:  Sanford P C Hsu; Tien-Yu Hsiao; Li-Chieh Pai; Chia-Wei Sun
Journal:  Neurophotonics       Date:  2022-03-23       Impact factor: 4.212

9.  Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma-a narrative review.

Authors:  Simone Krebs; Julia G Barasch; Robert J Young; Christian Grommes; Heiko Schöder
Journal:  Ann Lymphoma       Date:  2021-06-30

Review 10.  Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.

Authors:  Lelio Guida; Vittorio Stumpo; Jacopo Bellomo; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.